Pharmaceutical powerhouse Neuland Laboratories has rewarded long-term investors with an astronomical 21,346% return over two decades, attracting big bets from veterans like Vijay Kedia.
- Neuland Laboratories witnessed a staggering 21,346% surge in share price over 20 years.
- An investment of ₹1 lakh in 2006 would now be worth approximately ₹2.15 crore.
- Renowned investor Vijay Kedia holds a 1.01% stake with 130,000 shares.
In the world of stock market investing, finding a 'multibagger' is the ultimate goal, and Neuland Laboratories has emerged as a textbook example of exponential wealth creation. The pharmaceutical company has delivered returns that are nothing short of legendary, turning modest investments into fortunes over the last two decades.
To put the numbers into perspective, on September 8, 2006, the shares were trading at ₹109.25. By September 11, 2026, the stock closed at ₹23,536.20 on the BSE. This represents a mind-boggling growth of 21,346%. For an investor who held their position from 2006, a seed investment of ₹1 lakh would have blossomed into a staggering ₹2.15 crore today.
Why This Matters
BozokMedia analysis shows that this trajectory is driven by the company's strategic positioning in the high-value API (Active Pharmaceutical Ingredients) market. The entry and sustained presence of high-net-worth individuals (HNIs) like Vijay Kedia and Mukul Mahavir Agarwal serve as a strong validation of the company's operational efficiency and future scalability.
"The magic of compounding is most visible in quality mid-cap stocks that evolve into industry leaders over decades."
The momentum has not slowed down in recent years. Over the last five years, the stock has surged by 1,226%. On September 9, 2021, the shares were priced at ₹1,766.80, climbing steeply to over ₹23,000 by late 2026. Even in the short term, the stock has shown resilience with an 83% jump in the last six months alone.
Institutional and veteran interest remains high. Vijay Kedia, through his investment vehicle Kedia Securities Private Limited, holds 130,000 shares. Meanwhile, investor Mukul Mahavir Agarwal has taken an even larger position with 400,000 shares, amounting to a 3.12% stake in the company.
| Time Horizon | Return (%) | Price Growth |
|---|---|---|
| 20 Years | 21,346% | ₹109 $\rightarrow$ ₹23,536 |
| 5 Years | 1,226% | ₹1,766 $\rightarrow$ ₹23,536 |
| 6 Months | 83% | Strong Uptrend |
Frequently Asked Questions
1. What is Vijay Kedia's stake in Neuland Laboratories?
Vijay Kedia holds 130,000 shares via Kedia Securities, representing a 1.01% stake in the company.
2. What is the 52-week high for Neuland Laboratories?
The stock reached a 52-week high of ₹24,235.05.
